Johnson & Johnson Innovative Medicine is seeking a Senior Financial Analyst, US Innovative Medicine, Gross-to-Net, to be based in Titusville, New Jersey. This role offers a hybrid working schedule, combining in-office and remote work. The position focuses on Gross-to-Net (GTN), which involves strategic discounts and rebates provided to entities like government and commercial insurance payers within the complex pharmaceutical landscape. The role offers a deep understanding of the US healthcare system and the operations of supported brands. GTN is a critical and dynamic area with high visibility. The Senior Financial Analyst will provide financial leadership and business partner support for GTN aspects related to a portion of the Established Products Group (EPG) (Stelara/Ustekinumab, Remicade/Infliximab, Simponi, Simponi Aria), the Patriot portfolio, and total EPG GTN consolidations. This includes influencing key strategies and business decisions to ensure patient access to products within the evolving EPG portfolio. Additionally, the role has channel responsibility for actuals and forecast cycles for the US Innovative Medicine's AIDS Drug Assistance Program (ADAP) channel, Cash Discounts, and Sales Returns Reserve.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior